Abstract:Background. Endometrial carcinoma (EC) is one of the major gynecologic malignancy cancers affecting females with dismal prognosis and high mortality around the world. Numerous studies have proven that an aberrant level of long noncoding RNAs is present in many endometrial cancer patients, while the underlying molecular mechanism remains unclear. Method. The expression levels of lncRNA OIP5-AS1, miR200c-3p, and PTEN were measured by a quantitative real-time polymerase chain reaction in endometrial cancer tissue and endometrial cancer cells. CCK8 assay, wound-healing assay, and cell colony formation were applied to evaluate cell proliferation, cell migration, and cell colony formation ability. Cell cycle and cell apoptosis were detected by flow cytometry. The interactions between OIP5-AS1, miR200c-3p, and PTEN were explored by luciferase activity. Results. In the present study, we demonstrated that long noncoding RNA OIP5-AS1 was significantly reduced in EC tissue compared with normal tissue. The lower expression level of OIP5-AS1 was also confirmed in four kinds of EC cell lines compared with the normal endometrial cell line. Gain- and loss-of-function of experiments indicated that upregulation of OIP5-AS1 could inhibit the proliferation, migration, and invasion of EC cells in vitro. Meanwhile, overexpression of OIP5-AS1 could also suppress the growth of tumor in the xenograft model. Moreover, further study revealed that miR-200c-3p could bind to OIP5-AS1, and the loss function of miR-200c-3p could reverse the elevated OIP5-AS1’s inhibitory effect on the progression of EC. Furthermore, we found that downregulation of miR-200c-3p was inversely correlated with PTEN expression in EC cells. Reduced OIP5-AS1 could lead to the accumulation of miR-200c-3p, which could induce the upregulation of PTEN indirectly. Conclusion. Our study demonstrated a novel molecular mechanism that lncRNA OIP5-AS1 could modulate the progression of EC by combining competitively with miR-200c-3p to control the PTEN/AKT pathway in EC cells, which might supply important information for developing novel therapeutic strategies for EC patients.

A novel LINC00478 serves as a tumor suppressor in endometrial carcinoma progression

The oncogenic potentials and diagnostic significance of long non-coding RNA LINC00310 in breast cancer.

Identification and Validation of a Seven Cuproptosis-Associated Lncrna Signature to Predict the Prognosis of Endometrial Cancer

LINC00472 expression is regulated by promoter methylation and associated with disease-free survival in patients with grade 2 breast cancer

LINC00958 Promotes Endometrial Cancer Cell Proliferation and Metastasis by Regulating the Mir-145-3p/tcf4 Axis.

Long Non-Coding RNA LINC00672 Contributes to P53 Protein-Mediated Gene Suppression and Promotes Endometrial Cancer Chemosensitivity

Lnc-Na Inhibits Proliferation And Metastasis In Endometrioid Endometrial Carcinoma Through Regulation Of Nr4a1

Exploring lncRNA-Mediated Regulatory Networks in Endometrial Cancer Cells and the Tumor Microenvironment: Advances and Challenges

A Long Noncoding RNAs Signature to Improve Survival Prediction in Endometrioid Endometrial Cancer.

LINC00470 Stimulates Methylation of PTEN to Facilitate the Progression of Endometrial Cancer by Recruiting DNMT3a Through MYC

Long Non-Coding RNA LINC00467 Correlates to Poor Prognosis and Aggressiveness of Breast Cancer

Long Noncoding RNA LINC01554 As a Novel Biomarker for Diagnosis and Prognosis Prediction of Epithelial Ovarian Cancer

LINC00941: a novel player involved in the progression of human cancers

IGF2BP3 Enhances the Mrna Stability of E2F3 by Interacting with LINC00958 to Promote Endometrial Carcinoma Progression

LINC01572 promotes triple‐negative breast cancer progression through EIF4A3‐mediated β‐catenin mRNA nuclear exportation

A novel long non‐coding RNA LINC00524 facilitates invasion and metastasis through interaction with TDP43 in breast cancer

Roles, underlying mechanisms and clinical significances of LINC01503 in human cancers

Novel breast specific long non-coding RNA LINC00993 acts as a tumor suppressor in Triple negative breast cancer

lncRNA OIP5-AS1 Suppresses Cell Proliferation and Invasion of Endometrial Cancer by Regulating PTEN/AKT via Sponging miR-200c-3p

LINC00152 Promotes Tumor Progression and Predicts Poor Prognosis by Stabilizing BCL6 from Degradation in the Epithelial Ovarian Cancer

LINC00978 Promotes the Progression of Hepatocellular Carcinoma by Regulating EZH2-mediated Silencing of P21 and E-cadherin Expression